General ICU stuff Flashcards

1
Q

Protective effects of hypothermia

A
  • reduced CMR
  • Reduced cerebral O2 demand
  • decreased production of neurotraminssters
  • reduced free radical exposure and oxidative stress from reperfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Therapeutic hypothermia

A

Cooling patient to subnormal temperature for specific indication
previously used in OOHCA, TBI
now neonatal hypoxic brain injury and deep hypothermic circulatory arrest in aortic surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Targeted temperature management

A

constant targeted temperature maintained
unconscious cardiac arrest patient
- OHCA initial shockable rhythm (previous recommendation)
- OHCA initial non-shockable (previous suggestion)
CI to < 33 C include severe systemic infection and coagulopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TTM fallen out of favour

A

now avoidance of hyperthermia and maintenance of low normal temperature
TTM trial 33 vs 36 degrees OOHCA no difference in mortality or disability
TTM 48 33 degrees for 24 or 48 hours. no difference, sig more adverse events
TTM 2 33 vs 37.5 no difference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TTM methods

A

devices - feedback loop with monitoring and delivery - heat exchange water circulating cooling pads in arctic sun
simple ice packs
intravascular head exchanger
sedation with NMB due to shivering
rewarming risks of rebound hyperthermia, vasodilatory hypotension, reperfusion injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How would you manage temperature following cardiac arrest

A
  • temperature control
  • actively preventing fever > 37.7
  • use cooling device to target temperature of 37.5 if antipyretics, exposure etc unscuccesful
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How would you manage temperature following TBI

A

Normothermia aiming 36-37

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

challenges of nutritional assessment in ICU

A

patient
- extremes of prior health
- frailty
- varied population
illness
- acute gut injury
- sepsis
- major trauma
- organ failure
treatment
- ventilation
- RRT
- sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MUST score

A
  • BMI
  • % change
  • acute disease effects
    add scores for overall risk
    0 = low 2 or more = high
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

nutritional assessment on icu

A

ESPEN
- all patients > 48hr on icu risk of malnutrition
- pre icu weight loss, pre icu decline in physical performance
- muscle mass, body composition, strength

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

BMR

A

energy expended per unit time during rest.
40cal/m2/hr
energy expenditure is sum of internal heat produced and external work. internal heat = BMR + thermic effectst of food
critical illness - catabolic and significant energy deficit
measuring energy expenditure
- indirect calorimetry - need VO2 / VCO2
- feeding equations - Harris - Benedict, Schofield based on gender, age, sizue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

respiratory quotient

A

CO2 : O2 during respiration
carb = 1.0 protein 0.8 lipid 0.7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

body weight terms

A

actual / total = measured weight
LBW - excludes fat
IBW - based on height
ABW - use in obese patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Daily nutritional requirements in critical illness

A

energy - 25-35kcal/kg
carb - 2g/kg
protein 0.8-1.5g/kg
lipid 1-1.5g/kg
water 30ml/kg
Na K Cl 1mmol/kg
PO4 0.4mmol/kg
Mg and Ca 0.1mmol/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nutritional support

A

oral supplements, EN, PN
- increased risk of malnutrition
- little or no diet for 5 days, continuing another 5 days
- poor absorption
- high nutritional loss
- high demand

ESPEN - EN via NG within 48hrs once stable
50% of estimated target, increase to 70% after 48hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

contraindications to EN

A
  • gut - anastatmotic leak, necrosis, ischaemia
  • maintaining oral inake
  • peritonitis
  • uncontrolled severe shock
    relative
  • > 500ml gastric aspirate/6 hrs
  • abode compartment syndrome
  • < 5 days fasting
  • localised peritonitis, abscess

EN disadvantages
- needs healthy gut
- tube discomfort
- tube misplacement
- diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

trophic feeding

A

minimal administration of EN <20% requirements to preserve gut integrity rather than nutrition
- preserves epithelium
- prevents translocation
- enhance immune function

permissive underfeeding is deliberately administering < 70% of target calories.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Parental nutrition

A

IV administered sterile nutrients
central access due to risk of thrombophlebitis and infection
lipid triglycerides 40% non protein calories
carbohydrates mainly glucose 60%
all essential amino acids
electrolytes
trace elements and vitamins separately
late day 8 plus probably better than early

protein increased supplementation in burns, trauma, neck fas
decreased in hepatic encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

stress ulceration

A

stress mediated mucosal injury can be caused by critical illness, maybe due to hypoxia, hypo perfusion, coagulopathy
deep ulcers may cause haemorrhage or perforation
compared to PUD - usually affects gastric fungus and is painless

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

GI bleeding in critical care

A

highest risk
- mechanical ventilation without EN
- CLD
High risk
- coagulpathy
Mod risk
- mechanical ventilation with EN
- AKI
- Sepsis
- shock
Low risk
- steroids
- anticoagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

stress ulcer prophylaxis

A
  • enteral feeding
  • pharamcoglocial prophylaxis (PPI / H2)
    • if high or highest risk
    • avoid f low risk of bleeding - increase bacterial overgrowth and HAP (potentially also CDI)
  • cautious vasopressors
  • optimised fluid status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Plasmaphoresis vs PLEX

A
  • Aphoresis - removal of component of patients blood using extracorporeal circuit
  • plasmapheresis - type of aphorises removing plasma
  • plasma exchange - plasmapheresis and replacement with substitute - removing high molveculr weight substances causing pathology. 100-150% of plasma exchanged, often 5 exchanges. 5% HAS replacement

other therapeutic aphorises
- leucopheresis
- thrombocytaphoresis
- erythrocytaphersis (severe malaria, sickle cell crisis, polycythaemia ruby vera)
- rheaphoresis - separate high molecular weights

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how does plasmaphoresis work?

A

two methods
- centrifugation - blood spins to separate components by density. used in donation
- filtration - blood passes through specialised filter to separate components - similar set up to RRT, can be adapted for PLEX with replacement fluid given back to bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indications for PLEX

A

Category 1
- Neuro - GBS, acute MG, NMDA encephalitis
- Renal - ANCA-vasculitis, anti-GBM, GPA
- Haem - TTP, catastrophic APLS
- Post transplant - desensitisation in ABO incompatibility
Category 2
- Neuro - ADEM, LEMS, MS, VGKC disease, chronic MG
- Renal - amyloidosis
- Haem - AIHA
- Transplant - antibody mediated rejection
- Other - thyroid storm, SLE severe complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Category IV (ineffective / harmful) PLEX

A
  • ALS
  • Rheumatoid arthritis
  • schizophrenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Complications of PLEX

A
  • dilution coagulopathy
  • complications of access
  • transfusion reaction
  • fluid imbalance / hypovolaemia
  • complications of anticoagulation
  • drug dose alterations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

post-intensive care syndrome

A

constellation of physical and psychological syndromes affecting patients following intensive care stay
- physical - weakness, pain, reduced mobility, breathlessness
- mental health - PTSD, anxiety, depression
- cognitive - memory loss, difficulty concentrating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Sequelae of critical care admission

A

RESP - laryngeal injuries, voice changes, stenosis. Pulmonary hypetension, embolism, fibrosis, long term trachesotomy
CVS - LV / RV dysfunction
RENAL - AKI, CKD, RRT dependence
NEURO - seizures, HII, focal deficit, cognitive deficit
NUTRITIONAL - appetite loss, dysphagia
PHYSICAL - ICUAW, joint pain, pressure sores
COMMUNICATION - difficulties
PSYCHOLOGICAL
FATIGUE
CHRONIC PAIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Identifying rehab needs

A

prevention e.g. minimises IPPV
Screening - within 4 days, prior to discharge, on the ward. PICCUPS tool / Chelsea critical care assessment tool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Considerations when assessing critical care related morbidity

A
  • LOS
  • Severity of illness
  • Severity of longterm injury e.g. neurology
  • premorbid respiratory and physical function
  • nutritional issues
  • psychiatric e.g. recurrent nightmares, intrusive thoughts, hallucinations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Rehab goals

A

short, medium, long term
achievable and can change
regular assessment and MDT
e.g. goal of early mobilisation
early - sit on edge of bed with support
medium - stand aided
long - march on spot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Handover from critical care

A

Summary of stay including management and diagnosis
monitoring and investigation plan
plan for ongoing treatment
individualised rehab programme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Discharge from hospital

A

Discussion about
- physical and cognitive recovery
- psychological and emotional recovery
- diet
- continuing treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

follow up of critical care patients

A
  • more than 4 day admission should be followed up at 2-3 months
  • assessment of new physical and non-physical problems
  • rate of recovery
  • social care / equipment
  • arranging support
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Sepsis 3 definitions

A

Sepsis = life threatening organ dysfunction caused by deregulated host response to infection
septic shock = vasopressors needed to maintain MAP > 65 and lactate > 2. 40% mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

SOFA score

A

6 organs 0-4
0 - 24
2 + = organ dysfunction = 10% mortality
Resp = P/f
CVS = MAP, vasopressors
Neuro = GCS
Renal - creatinine, UO
Coag = platelets
Liver = Bili

correlates with mortality
e.g. initial score 4-5 = 20% > 12 = 95%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Glycocalyx

A

layer of proteoglycans and glycoproteins semi bound to capillary wall. semi-permeable layer, allows passage of anions and small molecules. manages mediators such as NO
injury –> permeability alteration in starling forces and pro-inflammatory pathways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Pathophysiology of sepsis

A

Cascade of vicious cycles
initially PAMPs on microbe activate immune system via TLRs
transcription of pro inflammatory cytokines TNF, IL-1B
adhesion molecules, acute phase proteins, pro-oxidants pro-coagulant released
systemic injury when threshold exceeded by inflammatory response
- ROS - damage cells and DNA
- Complement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Surviving sepsis campaign 1 hr bundle

A
  • measure lactate
  • take cultures
  • give abx
  • administer 30ml/kg fluid if hypotensive or lactate > 4
  • vasopressors if remains hypotensive

Timing of abx
- immediately if definite or probable sepsis or possible sepsis with shock
- possible sepsis without shock - 3 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

circulatory failure in sepsis

A

30ml/kg fluid < 3 hrs if hypo perfusion or shock
NA MAP > 65, peripheral if no cvc
consider VP if > 0.3mcg/kg/min
if cardiac dysfunction consider dobutamine
add steroid if ongoing requirements > 4 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Early goal directed fluid therapy evidence

A

rivers 2001 - target MAP, CVP, ScVO2. significant improved mortality
Process, arise, promise - no difference

Rivers protocol
- 1st 6 hrs
- supplemental O2
- CVP 8-12
- MAP 65-90
- SCVO2 > 70%
- If < 70% - red cell transfusion if Hb < 100 or dobutamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

MAP targets evidence

A

SEPSISPAM - MAP 65-70 vs 80-85. no difference in mortality. less AKI in higher group with chronic hypertension
65 - ‘permissive hypotension’ MAP 60-65 in over 65s vs usual care. mean 66.7 vs 72.6. no difference in mortality. Chronic hypertensives faired better with lower MAP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Vasopressin evidence

A

VASST - add vasopressin to noradrenaline, no difference in mortality.

36
Q

Activated protein C

A

PROWESS - improved mortality
concern re bleeding events
PROWESS-SHOCK - no improvement.
withdrawn

37
Q

Evidence against in sepsis

A

starches
terlipressin
vitamin C
- CITRIS-ALI - no difference
- LOVIT - increased mortality

38
Q

Multi-organ dysfunction syndrome

A

2 or more organ systems altered function during acute illness such that homeostasis cannot be maintained
genetics, comorbidity, iatrogenesis, inflammation
severity depends on nature of insult, pre-existing organ reserve, therapies

39
Q

PRIS

A

Condition associated with propofol use
acute bradycardia plus
- metabolic acidosis (86%)
- rhabdomyolysis (45%)
- lipaemia (15%)
- enlarged fatty liver

40
Q

PRIS ECG

A

Brugada like changes coved STE V1-3
Arrhythmias
Bradycardia –> systole

41
Q

PRIS pathophysiology

A

imbalance of energy demand and utilisation
oxidative phosphorylation and FFA utilisation are impaired leading to lactic acidosis and muscle necrosis
propofol contributes to lipid load and negative chronotropy

42
Q

risk factors PRIS

A

high sedation requirements - TBI, sepsis
high endogenous catecholamine, glucocorticoids
low carb-lipid ratio
children have lower glycogen stores and high dependence on fat metabolism

43
Q

management of PRIS

A

stop propofol
pacing / chronotropy
adequate carbohydrate load
RRT
prevention
- propofol < 4mg/kg/hr
- sedation holds
- monitor CK and triglycerides

44
Q

delirium

A

acute, fluctuating, reversible disturbance in cognition and consciousness characterised by disorientation and inattention
29% on ICU
increased LOS, mortality, hospital acquired complications

45
Q

delirium types

A

hyperactive - heightened arousal, restless, agitatied
hypoactive - somnolescent, withdrawn, quiet
mixed - alternating between two

other features
- inattention
- delusions, hallucinations
- sleep wake cycle disturbance

46
Q

risk factors

A

patient
- age > 65
- alcohol
- pre-existing cognitive dysfunction
- sensory impairment
illness
- severity
- infection / sepsis
- hypoxia, hypotension
- constipation
- pain
management
- drugs e.g. benzodiazepines, opioids, steroids
environment
- lack of sleep
- lack of day-night routine

47
Q

diagnosis of delirium

A

4-AT
AMTS
CAM-ICU
- altered mental state or any fluctuation
- inattention - squeeze letter A CASABLANCA
- Altered level of consciousness RASS other than 0
- Disorgenised thinking - questions / commands
1 + 2 + 3/4

48
Q

management of delirium

A

prevention
- regular assessment
- sleep - wake - sleep hygiene, avoiding medications, eye masks, ear plugs
- avoid constipation
- minimise sedation
- analgesia
- avoid hypotension, hypoxia
- avoid causative medications
conservative
- re-orientation
- family present
- early mobilisation
- removal of lines
pharmacolgical
- management of agitation or psychosis
- antipsychotics
- clonidine
- Benzes if alcohol

49
Q

ICU-AW

A

Secondary muscle weakness occurring after critical illness
symmetrical, generalised, proximal weakness with low tone affecting limbs, respiratory muscles and sparing facial and oral muscles
- polyneuropathy
- polyneuromyopathy
- myopathy

50
Q

pathophysiology ICU-AW

A

muscle atrophy - immobilisation, disuse, unloading, denervation
muscle dysfunction - microcirculatory, structural alteration
neuropathy - oedema, microvascular dysfunction

51
Q

risk factors icu-aw

A

patient
- older, frailer, obese
disease state
- duration, severity, mechanical ventialtion, sepsis, MOF
- hyperglycaemia
Medications
- steroids, NMB, sedation

52
Q

diagnosis

A

clinical - MRC < 48/60, hand dynamoterey, 6mwt
electrophysiological - CMAP / SNAP
muscle biopsy
respiratory weakness
- max insp.exp pressure

53
Q

lagophthalmos

A

incomplete closure of eyes
- exposure keratopathy
- corneal abrasion

54
Q

eye infections

A

systemic fungal infection - affect eye and lead to visual loss
conjunctivitis - red and sticky eye, bacterial, viral. chloramphenicol eye ointment
microbial keratitis - HSV, bacteria - red watery sticky
endogenous endophthalmitis - red eye in septic patient, haematogenous spread

55
Q

Non-infective eye issues

A

ischemic optic neuropathy - hypotension, CRAO
acute glaucoma
chemises

56
Q

Poisoning presentatoions

A

accidental
intentional
recreational
suspect in undifferentiated
- altered consciousness
- respiratory depression
- cardiovascular instability
- vomiting
- seizures

57
Q

Cholinergic toxidrome

A

Pupils: miotic
Neuro: Sedation, seizures
Vitals: hypotension, bradycardia
Other: diaphoresis, SLUDGE
Causes: nerve agents, neostigmine, organophosphate

58
Q

Anti-cholinergic toxidrome

A

Pupils: myriatic
Neuro: agitation or sedation, seizures, clonus
Vitals: tachycardia, hypretension, hyperthermia
Other: urinary retention
Causes: antihistamines, TCA, hyoscine, parkinsons medications

59
Q

Sedative toxidrome

A

Pupils: Miotic
Neuto: sedation
Vitals: hypoventilation, hypotension, hypothermia, bradycardia
Other: constipation
Causes: opioids, alcohol, Benzes, barbiturates, GHB

60
Q

Stimulant toxidrome

A

Pupils: mydriatic
Neuro: agitation, seizures, tremor
Vitals: tachycardia, hypertension, hyperthermia, hyperventilation
Causes: cocaine, amphetamine, theophylline

61
Q

reduce effect of poisons

A

reduce absorption
- activated charcoal
- decontamination - emesis, lavage, whole bowel
- lipid sink - LAST
- skin decontamination
enhance elimination
- IV fluid
- extracorporeal
- urinary alkalisation
neutralise
- antidotes

62
Q

Extracorporeal removal of toxins

A

low protein binding, low Vd, low molecular weight
< 10kda dialysis < 25kda filtration

63
Q

drugs cleared by RRT

A

Haemodialysis (most)
- salicylates
- lithium
- carbamazepine
- metformin
- valproate
- alcohols
- aminoglycosides
- theophyllines
Haemofiltration
- lithium
- opioids
- sympathomimetics

64
Q

Specific antidotes

A

Opioids - naloxone
Benzos - flumazenil
Beta blocker - glucagon
cyanide - hydroxycobalamin
toxic alcohols - fomepizole / ethanol
Serotonin - cyproheptadine
Paracetamol - NAC
Digoxin - Digibind

65
Q

TCA Overdose

A

Anticholinergic toxidrome
Dysrhythmias (Na channel blockade)
Hypotension
Seizures
Delirium

66
Q

ECG in TCA overdose

A
  • Prolonged QRS (> 100 - seizure risk > 160 VT)
  • Prolonged QT
  • Sinus tachycardia
  • Right axis deviation
67
Q

Management priorities in TCA OD

A

General
- Toxbase
- Airway protection - seizures, loss of airway reflexes
- High flow O2
- CVS support - IV access, fluid, cardiac monitoring, vasopressors
- Seizure tx - benzodiazepines
Specific
- Na Bicarb - QRS > 100, seizure, hypotension

68
Q

Antipsychotic OD

A

Management principles
- Benzodiazepines for agitation
- supportive care - intubation
- delirium on emergence
Typical Antipsychotics (haloperidol) - fluctuant mental state, CNS depression, hypertension, tachycardia, anticholinergic
Atypical antipsychotics (olanzepine, risperidone) - respiratory depression, CNS depression, hypotension
Lithium
- Neuro - fine tremor, ataxia, nystagmus, myoclonus, seizure, coma
- GI - N, V, D
- CVS - bradycardia, hypotension, long QT

69
Q

Mx lithium toxicity

A

narrow therapeutic index - may be precipitated by polypharmacy, altered physiology
- lithium levels, renal function
fluid repletion
dialysis - level > 4-5 acutely, 2-3 chronically
- neuro decompensation
- renal dysfunction

70
Q

challenges of illicit drug use

A

common - 10% 16-60yr olds
presentation - covert, secondary. lethality of overdose, contamination of substances
pharmacological - unpredictable dynamics, infections with prescribed, evolving chemical substances
others
- behavioural -aggression, intoxication
- capacity issues
- concomitant psychiatric conditions
- social issues
- complications of long term use - vascular access, abscess, manutirition

71
Q

drug of abuse classification

A

by desirable effect
- narcotics - heroin
- sedatives - alcohol, benzodiazepines, barbiturates, GHB
- stimulant - cocaine, MDMA
- hallucinogenic - mushrooms, acid, ketamine
- anabolic - steroids

recreational, therapeutic, physical or psychological dependencea

72
Q

approach to agitated intoxicated patient

A

pragmatic approach, unclear diagnosis
maintain safety - security
assessment of capacity / compliance with mx
de-escalation strategies
extreme agitation (threat to self or others)
- rapid tranquillisation
- GA e.g. facilitate CT
manage underlying cause of agitation
- urinary retention
- cocaine / MDMA - benzos
manage complications
- serotonin syndrome

73
Q

unconscious intoxicated patient

A

conscious state, pupils, reflexes, airway protection
intubation - risk of aspiration, failure of gas exchange, MODS
thiamine if risk of wernickes encephalopathy
causes
- ethanol, toxic alcohols
- opioid
- other overdose
Rule out DDX - meningoencephalitis, sepsis, myxoedema, ICH

74
Q

Alcohol intoxicaion

A

disinhibition, stupor, coma
complications - dehydration, hypoglycaemia, ketoacidosis, lactic acidosis, hypokalaemia, dysrthyhmias

75
Q

toxic alcohols

A

can be screened for, or treated if clinical signs and symptoms

76
Q

Ethylene glycol toxicity

A
  • antifreeze, detergents
  • alcohol dehydrogenase –> glycoaldehyde –> oxalic acid
  • toxic metabolites cause effects - calcium oxalate precipitates in kidney and brain
    stage 1 - 30mins - 2hrs - similar to ethanol toxicity + coma, seizures
    stage 2 12-24hr - myocardial dysfunction, MODS
    stage 3 24-72hr - AKI
    stage 4 72hr + - cranial nerve defects
77
Q

methanol toxicity

A
  • antifreeze, wiper fluid, paint remover
  • home distillation
  • alcohol dehydrogenase to formaldehyde –> formic acid
    0-6hr- similar to ethanol
    6-30hr - latent phase
    6-72hr - visual symptoms (blurring, snowstorm, blindness) seizures, coma, cerebral oedema
78
Q

isopropyl alcohol

A

hand sanitisers, antiseptic
metabolised by alcohol dehydrogenase to acetone
isopropanol - direct toxic effects from GABA agonism
profound intoxication - haemorrhage gastritis, cerebellar signs, coma

79
Q

toxic alcohol treatment

A

bicarb - pH 7.35-45 (alkalisation of urine, enhances elimination)
cofactors - pyridoxine, thiamine
fomepiazole
- competitive antagonist of alcohol dehydrogenase
- 15mg/kg
- serum concentration > 20mg/dl or
- osmolar gap > 10, pH < 7.3, HcO3 > 20
haemodialysis
- concentration > 50
- pH < 7.25
- visual disturbance, AKI, refractor electrolyte abnoramlity

osmolar gap = difference between calculated (2xNa + urea + glucose) and measured osmolarity.

80
Q

GHB

A

Gamma hydroxybutyrate
euphoria, CNA and respiratory depression, rapidly eliminated

81
Q

features in common with toxic alcohol poisonings

A

high anion gap
high osmolar gap
rapid absorption
metabolites and unchanged drug cleared by kidneys
all cause inebriation

82
Q

Serotonin syndrome

A

altered mental state
autonomic instability
neuromuscular excitability

serotonin produced from metabolism of tryptophan - neurotransmitter, then reupatke and inactivated by MAO
thermoreception, behaviour, attention, platelet aggregation
mechanisms
- excessive formation of precursors (LDOPA)
- increased released - cocaine, MDMA
- receptor stimulations - TCA, pethidine, fentanyl
- decreased reuptake _SSRI, tramadol
- decreased metabolism - MAOI

83
Q

serotonin syndrome presentation

A

benign –> life threatening
Altered mental status - confusion, agitation, delirium
Neuromuscular excitability - clonus, Hyperreflexia, hypertonia, tremor, rigidity
Autonomic - Labile BP, flushing, diaphoresis, hyperthermia
high index of suspicion - hunter serotonin toxicity criteria - 1 feature + history of serotniergic agent

84
Q

DDX serotonin syndrome

A
  • thyrotoxicosis
  • MH
  • heat stroke
  • NMS
  • sedative withdrawal
85
Q

Neuroleptic malignant syndrome

A

systemic deficit in dopamine
idiosyncratic reaction to neuroleptics or withdrawal of dopamine agonists
tetrad
- altered mental state
- rigidity
- autonomic instability
- hyperthermia

compared to serotonin syndrome - more rigidity, Hyperreflexia are. catatonia, encephalopathy, coma. insidious onset. rhabdo and MODS
supportive mx, benzos, dantrolene

86
Q

calcium channel blocker OD

A

elongating preparations, concomitant CVS disease
can lead to refractory hypotension as well as bradycardia, heart block, multi-organ hypo perfusion
- vasoactive agents - catecholamines
- calcium chloride
- vasopressors - metaraminol
- hyperinsulinaemic euglycaemic therapy (HIET)
- high dose glucagon
general - echo (pump failure vs vasodilation), early intubation, decontamination if modified release

87
Q

HIET

A

useful in myocardial dysfunction
intracellular transport of substrate and oxygen
might help weaning of high dose catecholamine infusions
- bolus 1unit/kg insulin following 1unit/kg/hr, titrated up to 10unit/kg/hr
- 50% dextrose 50-100ml concurrently followed by 1ml/kg/hr
- close monitoring glucose with moderately high target. titrate to BP > 90 HR > 60
maye also be used in severe beta blocker OD

88
Q

Beta blocker OD

A

Glucagon and milrinone - indirect sympathomimetic effects (not reliant on beta receptors)
increased myocardial cAMP
positive iontrotopr and chronotyopu
bradycardia and myocardial suppression more likely to respond than vasodilation

89
Q

salicylate toxicity

A

respiratory alkalosis before HAGMA
nausea vomiting tinnitus
seizures, hypotension, low GCS. hyperthermia
urinary alkalisation with bicarbonate
500mg/l mod 750mg/l severe
haemodialysis
- failure of urinary alkalinsation
- end organ impairment
- > 1000mg/l

90
Q

digoxin toxicity

A
  • narrow therapeutic index
    GI symptoms then CNS (chronic - progressive CNS)
    GI - N/V/D/pain
    CVS - bradycardia, AV block, AF, junctional, bigeminy
    neuro - visual disturbance, delirium, sieuzres
    digoxin specific Ab
91
Q

LAST

A

early - dysphoria, tinnitus, perineal numbness, metallic taste
CNS - agitation, LOC, seizures
CVS - heart block, bradycardia, systole, VT

92
Q

Mechanisms of LAST

A

systemic absorption / IV injection
affected by agent, dose, patient
interference of conduction in heart and brain
risk factors
- long acting
- more vasoactive agents - bupivacaine vs levobupivacaine
- proximal block
- use of adjuncts
- bilateral blocks

93
Q

Reducing risk of LAST

A

pre-procedure - assessment, dose calculation
procedure - USS, aspiration, serial injection
post-procedure - labelling of catheters, NRFiit
institutional - availability of lips emulsion

94
Q

Mx LAST

A
  • stop infusion
  • ABC
  • lipid emulsion
  • hyperventilation
  • seizure managagement - benzo, porropofol
  • antiarrhythmics as usual
  • e-cpr

Intralipid 20% dose
1.5ml/kg bolus
15ml/kg/hr infusion
repeat bolus 3x
max dose 12ml/kg

95
Q

corrosive ingestion

A

acid / alkali
readily available
airway compromise, GI perforation, strictures
decontamination, airway intervention, endoscopy

96
Q

acute heavy metal ingestion

A

GI irritation - N/V/D, fluid loss, electrolytes and dose related systemic toxicity
iron - ALF, cirrhosis
Lead - encephalopathy
arsenic - hypersalivation, encephalopathy, peripheral neuropathy
pro kinetics, endoscopy
iron - chelation with dexferrioamine
arsenic - chelation with succimer

97
Q

chemical weapons

A

nerve agents - organophsphares irreversibly bind to anticholinesterase - cholinergic toxidrome
managed with anticholinergic infusion, cholinesterase reactivator - pralidoxime
cyanidses - impair aerobic respiration, severe refractory lactic acidosis. supportive oxygenations, hydroxycobalamin

98
Q

acute radiation syndrome

A

whole body irradiation
significant history and lymphopenia
dose dependent
- large dose, external, penetrating, delivered over short time
prodrome, latent, manifest illness, death or recovery
manifestations
- bone marrow destruction
- GI destruction
- CVS . CNS syndrome
management - supportive, treat contamination, lymphocyte count expectant management and palliative care

99
Q

mental health and critical care

A

common admission
repeat admissions
evolving medications
complex polypharmacy
ECT
dilirium and withdrawal symptoms
refusal of medical interventions
need psychiatric follow up
may need detention under mental health act